REG - IQE PLC - IQE plc: Director/PDMR Shareholding

IqeAnnouncement

18/05/2023 11:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230518:nRSR8948Za&default-theme=true

RNS Number : 8948Z  IQE PLC  18 May 2023

IQE plc

 

Cardiff, UK

18 May 2023

 

Director/PDMR Shareholding

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading supplier of compound
semiconductor wafer products and advanced material solutions to the global
semiconductor industry, has been notified that, on 18 May 2023, the following
purchases of ordinary shares of 1p each ("Ordinary Shares") were made as part
of their participation in IQE's placing, the results of which were announced
on 18 May 2023.

 Names               Position                              No. Ordinary Shares acquired  Resultant holding*  % issued share capital*
 Americo Lemos       Chief Executive Officer               7,500,000                     8,470,457           0.89%
 Dr Andrew W Nelson  President and Non-Executive Director  5,000,000                     45,567,234          4.77%
 Phil Smith          Chairman                              100,000                       140,000             0.01%
 Carol Chesney       Non-Executive Director                50,000                        90,000              0.01%
 Victoria Hull       Non-Executive Director                50,000                        281,192             0.03%

 

*as at admission of the 150,000,000 new Ordinary Shares issued as a result of
the Placing, expected to take place on or around 22 May 2023.

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 1.  Details of the Person discharging managerial responsibilities ("PDMR") /
     person closely associated with them ("PCA")
 a)  Name                                     1.   Mr Americo Lemos

                                              2.   Dr Andrew W Nelson

                                              3.   Phil Smith

                                              4.   Carol Chesney

                                              5.   Victoria Hull
 2.  Reason for the notification
 a)  Position / status                        1.   Chief Executive Officer

                                              2.   President and Non-Executive Director

                                              3.   Chairman

                                              4.   Non-Executive Director

                                              5.   Non-Executive Director
 b)  Initial notification / amendment         Initial notification

 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     IQE plc

 b)  Legal Entity Identifier                  213800Y33WHD3ESJJP16

 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Ordinary shares of 1 pence each in the Company

GB0009619924

 b)  Nature of the transaction                Award of shares

 c)  Price(s) and volume(s)                   Price  Volume
                                              1.  20.0p  7,500,000
                                              2.  20.0p  5,000,000
                                              3.  20.0p  100,000
                                              4.  20.0p  50,000
                                              5.  20.0p  50,000
 d)  Aggregated information                   n/a - single transactions

     ·       Aggregated volume

     ·       Aggregated price
 e)  Date of the transaction(s)               18 May 2023

 f)  Place of the transaction                 Off-market

d)

Aggregated information

·       Aggregated volume

·       Aggregated price

n/a - single transactions

e)

Date of the transaction(s)

18 May 2023

 

f)

Place of the transaction

Off-market

 

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

 

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

Richard Chambers

James Smith

 

Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubenstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

 

ABOUT IQE

http://iqep.com
(https://www.globenewswire.com/Tracker?data=yZf7NKp1JKLALUCxlBuC8wkLnLAqoe5-kjjIlkMIDci9q9W0x_02bwZV-eorSbpLXZxy4zi3xHh-O4FM8nWjeg==)

 

IQE is the leading global supplier of advanced compound semiconductor wafers
and materials solutions that enable a diverse range of applications across:

 

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in
this market which has high barriers to entry. IQE supplies the global market
and is enabling customers to innovate at chip and OEM level. By leveraging the
Group's intellectual property portfolio including know-how and patents, it
produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing
locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in
London.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHNKFBNCBKKOPD